Image 1_Multi-antigen MVA-vectored SARS-CoV-2 vaccine, GEO-CM04S1, induces cross-protective immune responses to ancestral and Omicron variants.tiff

Image 1_Multi-antigen MVA-vectored SARS-CoV-2 vaccine, GEO-CM04S1, induces cross-protective immune responses to ancestral and Omicron variants.tiff

<p>The design focus of the first-generation COVID-19 vaccines was on the use of the SARS-CoV-2 spike (S) protein as the primary vaccine immunogen to induce high levels of neutralizing antibodies. Efficacy was repeatedly disrupted due to the diminished neutralizing capacity of vaccine-induced a...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Amany Elsharkawy (18285577) (author)
مؤلفون آخرون: Shannon Stone (19779228) (author), Anchala Guglani (19779231) (author), Felix Wussow (256275) (author), JD Burleson (22599632) (author), Mary Hauser (22599635) (author), Arban Domi (4506175) (author), Pratima Kumari (13249669) (author), Todd R. Albrecht (22599638) (author), Chinonye Dim (19779237) (author), Mark Newman (805798) (author), Don J. Diamond (7354430) (author), Sreenivasa Rao Oruganti (22599641) (author), Mukesh Kumar (132604) (author)
منشور في: 2025
الموضوعات:
Genetic Immunology
COVID-19
vaccine
SARS-CoV-2
K18-hACE-2
B.1
XBB.1.5
T-cells
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة